Mark Watson

Director/Board Member at ABRDN HEALTHCARE OPPORTUNITIES FUND

76 year

Health Technology

Technology Services

Miscellaneous

Profile

Mark Watson is currently the Director at H.
Lee Moffitt Cancer Center & Research Institute, Inc. since 2009.
He is also currently serving as an Independent Trustee at abrdn Healthcare Opportunities Fund starting in 2022.
Previously, Mr. Watson held positions as Director at Sykes Enterprises, Inc. from 2018 to 2021, Director at BioDelivery Sciences International, Inc. from 2017 to 2022, and Director at Inhibitor Therapeutics, Inc. from 2014 to 2022.

Mark Watson active positions

Companies	Position	Start
ABRDN HEALTHCARE OPPORTUNITIES FUND	Director/Board Member	08/06/2022
H. Lee Moffitt Cancer Center & Research Institute, Inc. H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research & contributions to clinical trials, prevention and cancer control	Director/Board Member	31/12/2008

All active positions of Mark Watson

Former positions of Mark Watson

Companies	Position	End
HEDGEPATH PHARMACEUTICALS INC	Director/Board Member	12/12/2022
BIODELIVERY SCIENCES INTERNATIONAL, INC.	Director/Board Member	01/01/2022
SYKES ENTERPRISES, INCORPORATED	Director/Board Member	01/01/2021

See the detail of Mark Watson's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Watson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Sykes Enterprises, Inc. Sykes Enterprises, Inc. Information Technology ServicesTechnology Services Provides business process outsourcing services	Technology Services
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain	Health Technology
abrdn Healthcare Opportunities Fund abrdn Healthcare Opportunities Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust	Miscellaneous
H. Lee Moffitt Cancer Center & Research Institute, Inc. H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research & contributions to clinical trials, prevention and cancer control	Commercial Services
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals	Health Technology

See company connections